| 1 |
30876866 | A role for foregut tyrosine metabolism in glucose tolerance. | 2019 May |
3 |
| 2 |
16403819 | Congenital hyperinsulinism: pancreatic [18F]fluoro-L-dihydroxyphenylalanine (DOPA) positron emission tomography and immunohistochemistry study of DOPA decarboxylase and insulin secretion. | 2006 Mar |
1 |
| 3 |
16339749 | Possibility of autocrine beta-adrenergic signaling in C2C12 myotubes. | 2005 Dec |
5 |
| 4 |
15258132 | Levodopa with carbidopa diminishes glycogen concentration, glycogen synthase activity, and insulin-stimulated glucose transport in rat skeletal muscle. | 2004 Dec |
5 |
| 5 |
12373520 | L-DOPA: from a biologically inactive amino acid to a successful therapeutic agent. | 2002 |
1 |
| 6 |
10069661 | GH-binding protein in obese men with varying glucose tolerance: relationship to body fat distribution, insulin secretion and the GH-IGF-I axis. | 1999 Feb |
1 |
| 7 |
6749630 | Effect of L-dopa administration on insulin binding: possible role of growth hormone in regulation of insulin receptor affinity. | 1982 Jul |
3 |
| 8 |
64868 | Success and problems of long-term levodopa therapy in Parkinson's disease. | 1977 Feb 12 |
1 |
| 9 |
320826 | Secretion of human growth hormone and insulin in levodopa test during carbamazepine therapy. | 1977 Feb |
1 |
| 10 |
591612 | Differential effects of L-dopa and apomorphine on glucagon secretion in man: evidence against central dopaminergic stimulation of glucagon. | 1977 Dec |
1 |
| 11 |
824407 | Weight loss in patients treated long-term with levodopa. Metabolic aspects. | 1976 Nov |
1 |
| 12 |
1278195 | Effects of long-term L-dopa therapy on carbohydrate metabolism in patients with Parkinson's disease. | 1976 |
2 |
| 13 |
4722572 | Plasma growth hormone and insulin response to levodopa and amantadine. | 1973 |
1 |